METHODS AND COMPOSITIONS FOR PROLONGING SURVIVAL AFTER ORTHOPIC AND HETEROTOPIC TRANSPLANTATION OF XENOGENIC HEART, KIDNEY, LUNG OR LIVER Russian patent published in 2023 - IPC A61K31/436 A61K35/12 A61K48/00 A61K35/407 A61K35/42 A61K35/34 A61K35/22 A61P37/04 

Abstract RU 2795429 C2

FIELD: medicine.

SUBSTANCE: transplantation and immunology, intended for prolonging the survival of a recipient organism after transplantation. To prolong the survival of the recipient organism, which is transplanted with a genetically modified heart, kidney, lung or liver from a xenogeneic donor organism, an immunosuppressive maintenance therapeutic agent is administered to the recipient organism in accordance with the administration scheme; administering one or more antihypertensive agents to the recipient organism in accordance with the administration scheme; administration of an mTOR inhibitor to the recipient organism in accordance with the administration scheme. Then the dose of glucocorticoid administered to the recipient organism is reduced by at least 5 times within 5 days after transplantation. The donor organism is a primate. In other embodiments, the use of a composition containing an mTOR inhibitor and the use of a composition containing one or more antihypertensive agents in this method are provided.

EFFECT: ensuring the prolongation of the survival of the recipient organism after transplantation due to the prevention of the growth of the donor organ in the recipient organism.

33 cl, 25 dwg, 5 tbl, 7 ex

Similar patents RU2795429C2

Title Year Author Number
AGENTS SUPPRESSING REJECTION OF TRANSPLANT 2002
  • Suzuki Sejiti
  • Isobe Mitsuaki
RU2263512C2
METHOD OF OBTAINING CELLS OF MONOCYTE ORIGIN INDUCING TRANSPLANT ACCEPTANCE, METHOD OF OBTAINING PHARMACEUTICAL COMPOSITION SUPPRESSING TRANSPLANT REJECTION REACTION, CELLS OF MONOCYTE ORIGIN INDUCING TRANSPLANT ACCEPTANCE, CELL MEDICINE FOR TRANSPLANT ACCEPTANCE INDUCTION, PHARMACEUTICAL COMPOSITION SUPPRESSING TRANSPLANT REJECTION REACTION, APPLICATION OF CELLS INDUCING TRANSPLANT ACCEPTANCE (VERSIONS),METHOD OF OBTAINING AND/OR REPRODUCTION OF REGULATORY T-LYMPHOCYTE, HYBRIDOMA CELL LINE, ANTIBODY AND ANTIBODY APPLICATION 2003
  • Kremer Bernd Karl Fridrikh
  • Fendrikh Fred
  • Runke Maren
RU2370535C2
AGENTS FOR SUPPRESSING TRANSPLANTED ISLAND DAMAGE FOLLOWING ISLAND TRANSPLANTATION 2006
  • Jasunami Jokhiti
RU2446826C2
METHOD FOR OBTAINING TRANSGENIC ANIMAL 1990
  • Uajt Dehvid Dzhejms Grekhem
  • Vill'Jams Alan Frederik
RU2252533C2
METHOD FOR TRANSPLANTATION OF ANIMAL CELL, TISSUE OR ORGAN FOR A RECIPIENT AND PREPARATION FOR ITS IMPLEMENTATION 1990
  • Uajt Dehvid Dzhejms Grekhem
  • Vill'Jams Alan Frederik
RU2195956C2
CHRONIC REJECTION INHIBITOR 2008
  • Takakhasi Masafumi
  • Izava Atsusi
RU2450829C2
PROLONGATION OF ALLOGRAFT SURVIVAL BY COMPLEMENT ACTIVITY INHIBITION 2007
  • Roter Rassell P.
  • Van Khao
  • Chzhun Chzhen'
RU2445975C2
POPULATION OF PIGS WITH LOW LEVELS OF PORCINE ENDOGENOUS RETROVIRUS AND ITS APPLICATION 2006
  • Ehlliott Robert Bartlett
  • Garkavenko Ol'Ga
  • Fergjuson Aleksander Berns
RU2412592C2
TRANSGENIC HOOFED ANIMALS, HAVING LOWER ACTIVITY OF PRION PROTEIN, AND THEIR APPLICATIONS 2003
  • Robl Dzhejms
  • Kuroiva Josimi
  • Tomizuka Kazuma
  • Isida Isao
RU2384059C2
CELL CULTURE TECHNIQUE 2017
  • Figueroa Bruno
  • Luan Yen-Tung
  • Wang Wenge
RU2709378C1

RU 2 795 429 C2

Authors

Reichart, Bruno

Abicht, Jan-Michael

Mayr, Tanja

Laengin, Matthias

Brenner, Paolo

Wolf, Eckhard

Klymiuk, Nikolai

Dates

2023-05-03Published

2019-03-29Filed